Latest News

New target for chronic pain treatment found

The enzyme PIP5K1C controls the activity of cellular receptors that signal pain, researchers have found. By reducing the enzyme, researchers showed that levels of a lipid called PIP2 is also lessened. They also found a compound that can dampen the activity of PIP5K1C. These findings could lead to a new kind of pain reliever for the more than 100 million people who suffer from chronic pain in the US.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Forget about the car keys, do you know when to take away your parent's checkbook?

  • Follow-up on psychiatric disorders in young people after release from detention

  • Teens with a history of TBI are nearly 4 times more likely to have used crystal meth

  • Stroke damage mechanism identified

  • Drug to reduce side-effects of 'binge drinking' developed

  • How do Tourette's patients react to visual stimulation with their own self-image?

  • 'Trigger' for stress processes discovered in brain

  • New research supporting stroke rehabilitation

  • Mindfulness treatment as effective as CBT for depression, anxiety

  • Fragile X study offers hope of new autism treatment

  •